Pfizer, Ranbaxy cardiovascular news

Pfizer said it was notified by the U.S. Patent and Trademark Office that the PTO will confirm the patentability of U.S. Patent No. 4,681,893 in a reexamination proceeding brought by Ranbaxy. The ‘893 ...